Show document

A+ | A- | | SLO | ENG

Title: INOVACIJSKA AKTIVNOST PODJETJA Authors: ID Irt, Katja (Author) ID Južnik Rotar, Laura (Mentor) More about this mentor... Files: 1253$$dn_irt_katja_08092025__pdf_a_drugic.pdf (844,78 KB) MD5: 5664D8854DF458EDF76CD5EF12190F59   Language: Slovenian Work type: Bachelor thesis/paper Organization: UNM FEI - University of Novo mesto - Faculty of Economics and Informatics Abstract: V dobi globalizacije, hitrih tehnoloških sprememb in naraščajočih zahtev po trajnostnih ter učinkovitih rešitvah predstavljajo vlaganja v raziskave in razvoj ter inovativnost ključne dejavnike konkurenčnosti in trajnostne rasti podjetij, saj omogočajo podjetjem, da razvijajo nove izdelke, izboljšujejo procese, uvajajo nove poslovne modele in se prilagajajo dinamičnim tržnim pogojem. Namen raziskave je proučiti, kako inovacijska aktivnost, z osredotočenostjo na vlaganja v raziskave in razvoj, vpliva na uspešnost podjetij Krka d. d. (v nadaljevanju Krka) in Novo Nordisk A/S (v nadaljevanju Novo Nordisk) z vidika prihodkov od prodaje, poslovnih rezultatov in inovacijske aktivnosti, ki jo merimo tudi s številom patentnih prijav. Poleg tega raziskava naslavlja tudi širši makroekonomski vidik vpliva izdatkov za raziskave in razvoj na bruto domači proizvod na prebivalca Slovenije in Danske. Rezultati analize kažejo, da višja vlaganja v raziskave in razvoj pomembno prispevajo h gospodarski rasti in izboljšanju konkurenčnosti podjetij. V Sloveniji so se ti izdatki v zadnjih letih povečevali, kar je prispevalo k rasti bruto domačega proizvoda na prebivalca, vendar država še vedno zaostaja glede inovativnosti v primerjavi z Dansko. Danska je s strateškimi ukrepi in dolgoročno podporo raziskavam dosegla višjo stopnjo inovativnosti in konkurenčnosti. Analiza podjetij Krka in Novo Nordisk je pokazala, da vlaganja v raziskave in razvoj pozitivno vplivajo na prihodke podjetij, saj se pri obeh podjetjih potrjuje povezava med rastjo izdatkov za R&R in doseženimi poslovnimi rezultati. Novo Nordisk je z intenzivnejšimi vlaganji v raziskave in razvoj dosegel izrazitejšo rast prihodkov in večjo dinamiko inovacij, kar mu omogoča ohranjanje vodilnega položaja na globalnem trgu, medtem ko je Krka z bolj zmernim, a dolgoročno usmerjenim pristopom k inovacijam dosegla stabilno rast in ohranila konkurenčnost. Keywords: Inovacije, izdatki za raziskave in razvoj, BDP p.c., Slovenija, Danska. Year of publishing: 2025 PID: 20.500.12556/ReVIS-12267  Publication date in ReVIS: 21.09.2025 Views: 132 Downloads: 3 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:	English
Title:	INNOVATIVE ACTIVITY OF THE COMPANY
Abstract:	In the era of globalization, rapid technological change, and increasing demands for sustainable and efficient solutions, investments in research and development (R&D) and innovation represent key factors of competitiveness and sustainable growth of companies. Such investments enable companies to develop new products, improve processes, introduce new business models, and adapt to dynamic market conditions. The purpose of this research is to examine how innovation activity, with a focus on R&D investment, affects the performance of Krka, d. d. (hereinafter Krka) and Novo Nordisk in terms of sales revenue, business results, and innovation activity, measured also by the number of patent applications. In addition, the research addresses the broader macroeconomic perspective of R&D expenditure and its impact on the gross domestic product (GDP) per capita in Slovenia and Denmark. The results of the analysis show that higher R&D investment significantly contributes to economic growth and improved competitiveness of companies. In Slovenia, these expenditures have increased in recent years, contributing to GDP per capita growth, although the country still lags behind Denmark in terms of innovativeness. Denmark, through strategic measures and long-term support for research, has achieved a higher level of innovativeness and competitiveness. The analysis of Krka and Novo Nordisk demonstrates that R&D investment positively affects company revenues, as both companies confirm the link between rising R&D expenditure and achieved business performance. Novo Nordisk, with more intensive R&D investment, has achieved stronger revenue growth and a higher pace of innovation, enabling it to maintain a leading position in the global market, while Krka, with a more moderate yet long-term innovation approach, has achieved stable growth and maintained competitiveness.
Keywords:	Innovation, research and development expenditure, GDP p.c., Slovenia, Denmark.

Back